A detailed history of Natixis Advisors, L.P. transactions in Stryker Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 158,087 shares of SYK stock, worth $61 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
158,087
Previous 149,231 5.93%
Holding current value
$61 Million
Previous $50.8 Million 12.48%
% of portfolio
0.11%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$315.94 - $371.96 $2.8 Million - $3.29 Million
8,856 Added 5.93%
158,087 $57.1 Million
Q2 2024

Aug 01, 2024

BUY
$324.3 - $354.67 $1.21 Million - $1.32 Million
3,716 Added 2.55%
149,231 $50.8 Million
Q1 2024

Apr 25, 2024

BUY
$293.94 - $358.71 $4.05 Million - $4.94 Million
13,773 Added 10.45%
145,515 $52.1 Million
Q4 2023

Feb 06, 2024

SELL
$253.85 - $299.46 $8.31 Million - $9.81 Million
-32,745 Reduced 19.91%
131,742 $39.5 Million
Q3 2023

Nov 13, 2023

BUY
$266.54 - $302.43 $986,997 - $1.12 Million
3,703 Added 2.3%
164,487 $44.9 Million
Q2 2023

Aug 15, 2023

BUY
$271.49 - $305.09 $4.31 Million - $4.85 Million
15,886 Added 10.96%
160,784 $49.1 Million
Q1 2023

May 11, 2023

BUY
$246.13 - $285.47 $9.04 Million - $10.5 Million
36,744 Added 33.97%
144,898 $41.4 Million
Q4 2022

Jan 27, 2023

SELL
$205.51 - $253.93 $37 Million - $45.7 Million
-179,903 Reduced 62.45%
108,154 $26.4 Million
Q3 2022

Nov 14, 2022

BUY
$189.27 - $231.83 $9.39 Million - $11.5 Million
49,621 Added 20.81%
288,057 $58.3 Million
Q2 2022

Aug 12, 2022

SELL
$194.09 - $276.37 $6.84 Million - $9.74 Million
-35,240 Reduced 12.88%
238,436 $47.4 Million
Q1 2022

May 12, 2022

BUY
$245.33 - $277.77 $1.15 Million - $1.3 Million
4,674 Added 1.74%
273,676 $73.2 Million
Q4 2021

Feb 08, 2022

BUY
$236.63 - $276.44 $2.91 Million - $3.4 Million
12,288 Added 4.79%
269,002 $71.9 Million
Q3 2021

Nov 15, 2021

BUY
$248.9 - $280.09 $1.77 Million - $1.99 Million
7,104 Added 2.85%
256,714 $67.7 Million
Q2 2021

Aug 12, 2021

BUY
$242.95 - $267.0 $5.67 Million - $6.23 Million
23,337 Added 10.31%
249,610 $64.8 Million
Q1 2021

May 05, 2021

BUY
$221.01 - $248.82 $1.8 Million - $2.02 Million
8,123 Added 3.72%
226,273 $55.1 Million
Q4 2020

Feb 12, 2021

BUY
$202.01 - $245.04 $7.59 Million - $9.21 Million
37,579 Added 20.81%
218,150 $53.5 Million
Q3 2020

Nov 12, 2020

BUY
$177.77 - $215.81 $2.42 Million - $2.93 Million
13,585 Added 8.14%
180,571 $37.6 Million
Q2 2020

Aug 11, 2020

BUY
$144.67 - $207.03 $7.21 Million - $10.3 Million
49,843 Added 42.55%
166,986 $30.1 Million
Q1 2020

Apr 27, 2020

BUY
$126.5 - $225.1 $2.5 Million - $4.45 Million
19,785 Added 20.32%
117,143 $19.5 Million
Q4 2019

Feb 10, 2020

BUY
$197.98 - $220.53 $139,575 - $155,473
705 Added 0.73%
97,358 $20.4 Million
Q3 2019

Nov 12, 2019

BUY
$205.4 - $221.82 $691,787 - $747,089
3,368 Added 3.61%
96,653 $20.9 Million
Q2 2019

Aug 12, 2019

BUY
$180.24 - $205.58 $619,665 - $706,784
3,438 Added 3.83%
93,285 $19.2 Million
Q1 2019

May 15, 2019

BUY
$152.46 - $198.0 $885,487 - $1.15 Million
5,808 Added 6.91%
89,847 $17.7 Million
Q4 2018

Feb 13, 2019

SELL
$145.0 - $178.65 $230,260 - $283,696
-1,588 Reduced 1.85%
84,039 $13.2 Million
Q3 2018

Nov 13, 2018

BUY
$163.25 - $177.68 $1.24 Million - $1.35 Million
7,593 Added 9.73%
85,627 $15.2 Million
Q2 2018

Aug 14, 2018

BUY
$155.17 - $179.78 $1.67 Million - $1.94 Million
10,785 Added 16.04%
78,034 $0
Q1 2018

May 10, 2018

SELL
$148.01 - $168.91 $3.07 Million - $3.5 Million
-20,747 Reduced 23.58%
67,249 $10.8 Million
Q4 2017

Feb 14, 2018

BUY
$143.51 - $159.74 $406,563 - $452,543
2,833 Added 3.33%
87,996 $13.6 Million
Q3 2017

Nov 14, 2017

BUY
$138.36 - $147.87 $11.8 Million - $12.6 Million
85,163
85,163 $12.1 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $146B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.